Sign In
Buy MIRM
$91.84
-0.335 (-0.363%)
At Close: Jun 03, 2026
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Tuesday, 11'th Aug 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
08:05pm, Friday, 07'th Aug 2020
Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
12:00am, Friday, 07'th Aug 2020
Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
08:05pm, Thursday, 06'th Aug 2020
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
12:00am, Thursday, 06'th Aug 2020
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09:00pm, Friday, 10'th Jul 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xconomy: Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease
09:04pm, Tuesday, 23'rd Jun 2020
Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired
Hedge Funds Are Nibbling On Mirum Pharmaceuticals, Inc. (MIRM)
06:06pm, Monday, 22'nd Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:10pm, Thursday, 11'th Jun 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Private Fund Structuring "101" - ValueWalk
07:04pm, Tuesday, 09'th Jun 2020
Although various factors influence the choice of entity structures used for a private fund, this memorandum will discuss the most basic
Mirum’s Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
12:30pm, Tuesday, 02'nd Jun 2020
Mirum’s Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
02:05pm, Friday, 29'th May 2020
Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
12:00am, Friday, 29'th May 2020
Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12:00am, Monday, 11'th May 2020
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
08:05pm, Thursday, 07'th May 2020
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
